Sorintellis
Ms. Diana Avramioti is the Chief Operating Officer of Sorintellis Group. Ms Diana Avramioti is a pharmaceutical industry professional in drug development, health economics, market access and reimbursement. She holds an MBA from HEC Montreal and a Masters in Pharmaceutical Sciences from the University of Montreal. She has extensive knowledge in drug development and commercial success. Diana began her career working for AMARIS consulting in the Health economics and Outcomes Research (HEOR). Diana moved to the pharmaceutical industry where she worked at PENDOPHARM a division of PHARMASCIENCE as senior associate in Health Economics and Market Access. She worked on developing strategic approaches for reimbursement and market access of Canadian products.
This person is not in any teams
Sorintellis
3 followers
Sorintellis is a Montreal-based company revolutionizing pharmaceutical portfolio management through a cutting-edge Ai-powered decision support system. Sorintellis' mission is to make clinical drug development faster and smarter by intelligently reducing the avoidable risks associated with clinical trials and improving the complex decision-making processes involved in managing pharmaceutical portfolios. Sorintellis' solutions are aimed at the pharmaceutical industry, contract research organizations (CROs) and life sciences hedge funds.